Lucite commemorative marking the research, development, and commercialization agreement between Sanofi and Regenereon. The pharmaceutical firms will focus on antibody cancer treatment s in the field of immuno-oncology.
(5ALR849)Lucite commemorative marking the research, development, and commercialization agreement between Sanofi and Regenereon. The pharmaceutical firms will focus on antibody cancer treatment s in the field of immuno-oncology.
(5ALR849)Lucite tombstone celebrating the initial public offering of biotech company Chiasma. The Massachusetts-based firm specializes in oral therapies for orphan diseases.
(6AEK859)Custom Lucite commemorating the private placement of shares issued by Cellectar. Madison, Wisconsin-based Cellectar focuses on developing cancer drugs and imaging tools.
(6ASHA20)Financial tombstone recognizing the acquisition of Croatian animal health products firm Genera. Genera’s products include poultry vaccines.
(6LAC881)Pill-themed tombstone commemorating two transactions in the Australian pharmaceutical sector.
(5SSC765)Financial tombstone commemorating a debt transaction related to the acquisition of World Nomad Group. WNG, an Australian distributor of travel insurance, was acquired by private health insurer nib.
(5SSC834)Lucite tombstone commemorating a follow-on offering for Vapor Corp. The company is a distributor and retailer of e-cigarettes and vaporizers.
(5AKL569)